Tempest Therapeutics Inc. (TPST)
NASDAQ: TPST
· Real-Time Price · USD
10.58
1.10 (11.60%)
At close: Aug 15, 2025, 3:59 PM
10.60
0.19%
After-hours: Aug 15, 2025, 05:47 PM EDT
11.60% (1D)
| Bid | 10.45 |
| Market Cap | 46.98M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -44.8M |
| EPS (ttm) | -14.52 |
| PE Ratio (ttm) | -0.73 |
| Forward PE | -0.71 |
| Analyst | Hold |
| Ask | 10.61 |
| Volume | 219,278 |
| Avg. Volume (20D) | 132,480 |
| Open | 9.50 |
| Previous Close | 9.48 |
| Day's Range | 9.30 - 10.90 |
| 52-Week Range | 5.36 - 20.67 |
| Beta | -1.91 |
About TPST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TPST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TPST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-15.88%
Tempest Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
2 months ago
+15.07%
Tempest Therapeutics shares are trading higher after the company announced it received orphan drug designation from the EMA for its amezalpat for the treatment of patients with hepatocellular carcinoma
